Sign In

Benjamin Schwartz, MD, MBA

Orthopedic Surgeon | Health Tech

Dr. Benjamin Schwartz, MD, MBA is a highly experienced Orthopedic Surgeon with a specialization in musculoskeletal care and a strong focus on evidence-based practices.

He holds leadership positions in prestigious healthcare associations such as the American Association of Hip and Knee Surgeons and the American Academy of Orthopaedic Surgeons, contributing significantly to the advancement of knowledge in the field.

With over 15 years of experience, Dr. Schwartz has excelled in value-based care, achieving substantial cost savings and earning accolades for his clinical expertise and professionalism.

Beyond his clinical work, he actively engages in healthcare technology and innovation, serving as an advisor and investor for early-stage digital health companies, where he leverages his expertise to bridge the gap between medicine and entrepreneurship.

Dr. Schwartz is dedicated to leveraging technology and innovation to enhance healthcare quality, accessibility, and outcomes.

His educational background includes an MD from Virginia Commonwealth University School of Medicine, an MBA from Quantic School of Business and Technology, and various specialized fellowship and residency programs.

Throughout his career, Dr. Schwartz has held key roles in multiple prestigious organizations, contributing to practice management, editorial boards, and advisory boards, showcasing his commitment to advancing the field of orthopedic surgery and musculoskeletal care.

Highlights

Aug 26 · linkedin

The Institute for Accountable Care is predicting that the average hospital will lose $900 per case in the TEAM model (schedule to begin in 2026).

Per IAC, some hospitals may lose close to $6,000 per case. And, as the chart shows, there will be over twice as many losers as winners.

TEAM participation is mandatory, and any loss on these cases is bad for hospital financials. When you consider that the biggest potential area of cost savings is reducing post-acute care, reducing its utilization hurts downstream revenue for vertically integrated systems who own VNAs, SNFs, and physical therapy.

There's also implications for what does on in the OR. Any expensive new technology or costly new implant could easily tip a case into the loss category. Vendors are already feeling the squeeze, and this won't help. Reference-based pricing is the new normal.

Like other VBC programs, there is always concern for cherry-picking and lemon-dropping, and TEAM will be no different. Expect tighter optimization protocols and more adoption of surgical hard and soft stops to reduce high risk (i.e., more expensive) procedures.

TEAM does include risk adjustment variables -- something that's a bit perplexing. Many surgeons (including me) raised the concern that BPCI did not include such mechanisms. CMS' reasoning was that risk averages out -- for every high-risk patient, there is a low risk one. The inclusion of risk adjustment in TEAM indicates they reconsidered this logic.

The report probably needs to be taken with a grain of salt (IAC drumming up some consulting business here). But this chart should get the attention of anyone who waves off VBC.

(H/t to the always informative Health Tech Nerds weekly newsletter)

#valuebasedcare #vbc #healthcare #medicine

Aug 16 · linkedin

Nick Aubin and I have been banging this drum for years. In fact, the idea of capital-conscious, value-focused, high touch, engaging, (thoughtfully) tech-enabled, hybrid MSK care is what brought the two of us together.

Based on years of experiencing the challenges and opportunities of frontline care delivery, I daydreamed (and bloviated) about the "Arthritis Centers of Excellence" concept. Turns out, Nick was already building it with Commons Clinic.

It's nice to see that others share the vision that physical clinics are underappreciated and overlooked. Turns out, the case has already been made many times over across the country by B&M practices, ASCs, and outpatient centers. These locations have been successful both clinically and financially.

They just haven't necessarily gotten attention from the VC/health tech community, Big Retailers, Big Tech, and others apprehensive about the time, cost, and risk associated with building or backing these efforts. This aversion is especially true for specialty practices and procedure-based physical locations.

It bears considering that, despite current day struggles, in-person care healthcare has a pretty strong track record. While we want to SaaS and quickly scale everything, traditional care delivery often succeeds in spite of technology, not (yet) because of it. We did OK before virtual care became a thing. Sure, things aren't perfect, but that's the opportunity. Something to ponder.

#medicine #healthcare #health #healthcareinnovation

Benjamin Schwartz, MD, MBA
Add to my network

Location

Greater Boston